SPOTLIGHT: Novartis makes the "Biggest Splash"

Thompson Scientific has released "Who's making the Biggest Splash," a quarterly review of scientific literature on drugs and therapies. The report provides an objective assessment of the quantity and quality of materials published by pharmaceutical companies and other research institutions. According to the research firm, Novartis has snatched the lead from GSK, which has dominated the ranking since June of 2006. Report

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.